A new programme announced by the FDA will work towards the use of augmented reality and virtual reality (AR/VR) to make patients’ own homes an integral part of the healthc
A new centre is to be set up in the UK to provide virtual reality-assisted training in medicines manufacturing, providing students with ‘near to real life’ experiences of
A virtual reality-based task could help differentiate people with Alzheimer’s disease from the normal cognitive impairment that occurs with age, according to a pilot study
People with depression can sometimes have impaired memory, particularly for positive events, which can contribute to cognitive problems and impair their daily lives.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh